“…Indeed, a combination of microarray and NGS-based experiments, assaying gene expression, DNA and histone epigenetic modifications, have profiled SkM in a multitude of contexts including loss/growth of muscle (Fisher et al, 2017;Viggars et al, 2023), acute and chronic exercise (Pillon et al, 2020;Seaborne et al, 2018aSeaborne et al, , 2018bShimizu & Kawano, 2022;Turner et al, 2019), lifestyle diseases (e.g. type 2 diabetes mellitus (Ribel-Madsen et al, 2012;Williams et al, 2020)), genetic diseases (Gonorazky et al, 2016), ageing (Ruple et al, 2021), sex-specific effects (Landen et al, 2019(Landen et al, , 2021 and anatomical location (Abbassi-Daloii et al, 2023). The use of traditional 'omic' strategies to profile and/or characterise the macromolecular landscape of SkM has typically focused on assaying SkM samples as biopsy homogenates (e.g.…”